In the early 80s, it was shown that the degree of anemia significantly contributed to bleeding time, and the subsequent introduction of recombinant erythropoietin and correction of anemia with hematocrit above 30%, resulted in significantly reduced bleeding time and severity of bleeding complications.3 Here, EPO is linked to anemia (phenotype).